Transcure Bioservices

Transcure Bioservices is a Paris-based preclinical CRO that provides specialized research services using proprietary humanized mouse models. The company focuses on accelerating drug discovery in oncology, inflammation, and infectious diseases by offering more predictive preclinical data through models that incorporate human biological systems. With approximately 70 employees and over 12 years of collective experience, Transcure positions itself as a flexible and transparent partner for biopharma companies, emphasizing tailored study designs and a collaborative approach. It is a private, likely revenue-generating services business, not a therapeutic developer.

Proprietary portfolio of humanized mouse models, including Human Immune System (CD34+), Humanized Liver, and Double Humanized (immune system + liver) models, designed to provide predictive preclinical data for drug efficacy and toxicity testing.

Transcure competes in the preclinical CRO space against large, full-service global CROs (e.g., Charles River, Labcorp) and other specialized providers of humanized mouse models (e.g., The Jackson Laboratory, Taconic Biosciences). Its differentiation lies in its specific focus on double-humanized models, personalized service approach, and deep expertise in immuno-oncology and inflammation models.